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Multiple long-term complications  
as a result of poor glycaemic control  
in type 1 diabetes — a case report
Liczne przewlekłe powikłania jako rezultat niedostatecznej kontroli glikemii  
u pacjenta z cukrzycą typu 1 — opis przypadku
ABSTRACT
We present a case of a 54-year-old patient with type 1 
diabetes affected by multiple microvascular and macro-
vascular complications. Over the course of the disease, 
he developed diabetic nephropathy that resulted in 
renal transplant, proliferative retinopathy of both eyes, 
and sensory polyneuropathy. He also suffered from 
arterial hypertension and diabetic foot syndrome, com-
plicated by an amputation of fourth left toe.
With the implementation of intensive insulin therapy 
(IIT), a decrease in prevalence of diabetic complications 
has been observed. Tight metabolic control, especially 
during early years of the disease, significantly reduces 
the risk of their development. However, there are pa-
tients who suffer from multiple complications, despite 
receiving IIT. One of the most important aspects of 
effective diabetes management is patients’ education 
and their active participation in the treatment. (Diabet. 
Klin. 2015; 4, 5: 199–203)
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STRESZCZENIE
W pracy przedstawiono przypadek 54-letniego pa-
cjenta chorującego na cukrzycę typu 1 z wieloma 
powikłaniami o charakterze mikroangiopatii i makro-
angiopatii. W przebiegu choroby u pacjenta rozwinęła 
się nefropatia cukrzycowa, która doprowadziła do 
przeszczepu nerki, retinopatia proliferacyjna obu oczu 
i polineuropatia czuciowa. Cierpiał też na nadciśnienie 
tętnicze oraz zespół stopy cukrzycowej, powikłany 
amputacją czwartego palca lewej stopy.
Wprowadzenie intensywnej insulinoterapii (IIT) dopro-
wadziło do zmniejszenia częstości powikłań o charak-
terze mikroangiopatii i makroangiopatii u pacjentów 
z cukrzycą typu 1. Ścisła kontrola metaboliczna, szcze-
gólnie w pierwszych latach choroby, istotnie obniża 
ryzyko ich wystąpienia. Pomimo tego u części chorych 
poddanych IIT nadal rozwijają się liczne powikłania. 
Jednym z najistotniejszych aspektów opieki nad pa-
cjentami z cukrzycą jest ich edukacja i aktywny udział 
w procesie leczenia. (Diabet. Klin. 2015; 4, 5: 199–203)
Słowa kluczowe: cukrzyca typu 1, powikłania 
cukrzycy, pamięć metaboliczna, edukacja pacjentów 
z cukrzycą, zdyscyplinowanie chorego
Introduction
Type 1 diabetes (T1DM) is usually diagnosed in 
children and adolescents, what entails the need of 
lifelong care. The only method of treatment is replace-
ment of endogenous insulin with injections of the 
exogenous hormone.
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Over the course of the disease, most patients 
develop long-term diabetic complications, which is de-
pendent on metabolic control of the disease, including 
not only blood glucose concentration, but also blood 
lipids and arterial blood pressure [1]. It is established 
that poor glycaemic management, indirectly assessed 
by the concentration of haemoglobin A1c (HbA1c), 
increases the risk of development and progression of 
long-term complications [2, 3].
The standard treatment for patients with T1DM 
includes tight glycaemic control with insulin, along with 
diet, physical exercise, blood glucose self-monitoring, 
and patient’s education. The Diabetes Control and Com-
plications Trial (DCCT) and its follow-up, the Epidemio-
logy of Diabetes Interventions and Complications (EDIC) 
study, have proven the superiority of intensive insulin 
therapy (IIT) over conventional treatment in achieving 
and maintaining near-normal concentration of blood 
glucose and its influence on development of long-term 
complications. IIT is also reported to reduce early stages 
of diabetic retinopathy, neuropathy, diabetic kidney dis-
ease, as well as more advanced stages of microvascular 
complications and cardiovascular disease [3].
Many studies have reported high prevalence of 
long-term diabetes-associated complications [4]. How-
ever, nowadays, when intensive diabetes therapy is 
considered the gold standard of treatment, it is rather 
uncommon to observe multiple microvascular and 
macrovascular complications in one patient with T1DM.
Case report
A 54-year-old patient with T1DM diagnosed 
33 years before, currently treated with IIT, was admit-
ted to hospital in February 2014 due to the diabetic 
foot syndrome. 
Two months prior to the hospitalisation, he pre-
sented at the doctor’s office complaining of painless 
reddening of fourth left toe. There was no history of 
preceding trauma. It quickly progressed to ulceration 
and despite surgical treatment necrosis and bone 
lesions developed. In January 2014, the patient un-
derwent the amputation of fourth left toe. One week 
later he was admitted to hospital with fever, fatigue, 
loss of appetite, dehydration, and fluctuations of blood 
glucose concentration. Infection of the amputation 
site with Staphylococcus aureus was then diagnosed. 
After two weeks, he was referred to the Department of 
Endocrinology, Diabetology, and Internal Medicine for 
further treatment and adjustment of diabetes control.
The patient had a history of multiple microvascular 
and macrovascular complications.
He suffered from diabetic kidney disease for 
8 years. Between 2008 and 2009, he was subjected 
to peritoneal dialysis, complicated by three incidents 
of peritonitis. Because of that, he was switched to 
haemodialysis in 2009. In June 2011, he underwent 
simultaneous pancreatic and renal transplant, fol-
lowed by pancreatic graft loss secondary to venous 
thrombosis one week later. However, the function of 
the transplanted kidney was preserved at the time 
of admission.
Proliferative retinopathy affecting both eyes oc-
curred at the age of 45. It was treated twice with laser 
photocoagulation 9 years before. The patient also 
underwent surgical treatment of cataract of the right 
eye in 2013. He complained of severely affected vision 
and difficulties with reading.
Symptomatic polyneuropathy occurred at the age 
of 44. He reported sensory neuropathy, with almost to-
tal loss of sensation in both feet, along with “tingling” 
and pain in the hands.
The patient presented arterial hypertension de-
veloped 28 years earlier. Despite him receiving com-
bination therapy, it was poorly controlled at the time 
of admission.
The patients had experienced three episodes of 
ulcerations in the course of diabetic foot syndrome. 
They had affected the patient’s left heel and medial 
surfaces of both feet. In any of the cases there had 
been no need for amputation.
Of relevant past medical history, he had under-
gone type C hepatitis treated with interferon between 
2009 and 2010. He was receiving complex hypotensive 
treatment (bisoprolol, indapamide, ramipril, amlodi-
pine) and atorvastatin, as well as immunosuppressive 
medications (everolimus, prednisone, mycophenolate).
Before admission, the patient was treated with 
IIT (insulin lispro 3 × 14 IU, insulin isophane human 
24 IU). He did not adhere to the doctor and dietician’s 
recommendations regarding diet and blood glucose 
self-monitoring.
On physical examination, body mass index (BMI) 
29.65 kg/m2 and blood pressure 146/92 mm Hg were 
found. Left foot was swollen, with features of an ongo-
ing inflammation at the site of amputation and ulcers 
of the sole. There was a significant deformation of the 
abdomen with a longitudinal scar in the midline (Fig. 1). 
The transplanted kidney could be palpated in the left 
iliac fossa.
The patient’s blood glucose concentration was 
poorly controlled. Fasting blood glucose ranged from 
86 to 294 mg/dL and postprandial glucose from 250 to 
300 mg/dL. The results of laboratory studies are pre-
sented in Table 1.
Doppler ultrasound of the lower limbs revealed 
few calcified atherosclerotic plaques, but otherwise 
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preserved blood flow in the arteries. Feet X-ray showed 
osteoporosis in the bones of the left foot. 
The patient was administered intravenous antimi-
crobial treatment, including ciprofloxacin, clindamycin, 
and cotrimoxazole, after which his condition improved 
significantly. He also received anticoagulants, anal-
gesics, as well as alpha-lipoic acid and alfacalcidol. 
Debridement of the infected wound was performed 
several times. Insulin therapy was modified — insulin 
isophane human was changed to insulin glargine, and 
the doses of both long-acting and rapid-acting insulin 
were modified to the patient’s needs (insulin lispro 8 IU 
– 10 IU – 10 IU, insulin glargine 30 IU). After that, a sat-
isfactory control of blood glucose concentration was 
achieved. Before discharge, the patient was educated 
about the importance of proper glycaemic control and 
risks of non-compliance with the recommendations.
Discussion
IIT has been the gold standard of treatment for 
patients with T1DM for over 20 years. It made meta-
bolic control of diabetes easier, and, consequently, 
a decrease in prevalence of diabetic complications has 
been noted in recent years [4–6]. Therefore, multiple 
diabetes-related complications in one patient are not 
commonly observed nowadays. In the study conducted 
by Morgan et al. [7], all five major complications were 
present in only 0.1% of patients. In contrast to these 
findings, our patient developed a large number of 
complications, including nephropathy, retinopathy, 
and polyneuropathy, as well as diabetic foot syndrome 
and hypertension.
The patient was diagnosed with T1DM in 1981, 
when IIT was not the standard method of treatment. 
Therefore, satisfactory metabolic control during first 
years of the disease was very difficult to achieve. This 
might have had a significant influence on the subse-
quent development of complications. An observational 
Figure 1. Deformation of the abdomen
Table 1. Results of the laboratory tests
Parameter Result Standard value PDA recommendations
HbA1c (%) 9.8 ≤ 7 ≤ 8
Total cholesterol [mg/dL] 209 130–200 < 175
LDL cholesterol [mg/dL] 105 100–159 < 100
HDL cholesterol [mg/dL] 67 35–55 > 40
Triglycerides [mg/dL] 169 40–200 < 150
WBC [103/µL] 7.39 4–10
RBC [106/µL] 4.39 4.5–6.0
Haemoglobin [g/dL] 10.8 14–18
Haematocrit (%) 33.8 40–54
PLT [103/µL] 203 130–350
CRP [mg/L] 61.7 0–10
Fibrinogen [mg/dL] 842 200–400
Urea [mg/dL] 60 10–50
Creatinine [mg/dL] 1.6 0.7–1.1
GFR [ml/min] 48 80–200
CRP — C-reactive protein; GFR — glomerular filtration rate; HbA1c — haemoglobin A1c; HDL — high density lipoprotein; LDL — low density lipoprotein;  
PDA — Polish Diabetology Association; PLT — platelets; RBC — red blood cells; WBC — white blood cells
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follow-up of DCCT, EDIC study, has revealed the exist-
ence of a phenomenon called “metabolic memory” 
[3]. Patients initially treated with IIT continued to show 
significantly lower rate of long-term complications, 
comparing with those previously assigned to conven-
tional treatment, even though their metabolic control 
deteriorated [8–11]. That disparity was explained 
mainly by differences in HbA1c between the two groups 
during DCCT. In the presented case, the patient had 
already been receiving IIT for several years. Despite 
that, he developed multiple complications, which is 
most probably associated with inadequate glycaemic 
control in the early years of the disease.
Another factor contributing to sufficient meta-
bolic control is patient’s comprehensive education 
and their conscious participation in the treatment 
process. Intensive diabetes therapy combines IIT with 
dietary interventions, physical activity, and frequent 
self-monitoring. Its success is dependent not only 
on the physician’s experience, but also — or maybe 
predominantly — on the patient’s attitude to disease 
and treatment. The association between patient’s 
diabetic knowledge and risk of developing long-term 
complications has been described by Araszkiewicz et 
al. [12]. The patients underwent a teaching programme 
followed by a test, and during a mean follow-up of 
7 years, development of microvascular complications 
was assessed. Those who developed retinopathy and 
albuminuria were found to present significantly lower 
diabetic knowledge, comparing with patients who 
remained free from microangiopathy.
It is worth accentuating that despite undergoing 
the same training programme, not all patients bene-
fitted from it. This may implicate the need to revise 
existing education schemes and implement interven-
tions tailored to the patient’s individual needs and 
concerns. A study by Hermanns et al. [13] suggests 
that programmes focused not only on glycaemic con-
trol, but also on emotional aspects of diabetes, are 
more effective in translating knowledge into everyday 
self-management, resulting in greater reduction of 
disease-related distress and an increase in diabetes em-
powerment.
It should be highlighted that although the pre-
sented patient received IIT, the treatment was based on 
fixed doses of insulin, regardless of actual concentra-
tions of blood glucose. This regimen is easy to follow, 
but does not provide ideal glycaemic control. Flexible 
intensive insulin therapy (FIT), in contrast, is more 
complex, but more effective in maintaining proper 
metabolic control [14]. FIT obliges patients to adjust 
insulin doses to the predicted carbohydrate intake, 
planned exercise, and current blood glucose, requiring 
comprehensive knowledge and conscious coopera-
tion with the doctor. The efforts result in more dietary 
freedom and better self-care, as well as lower risk of 
long-term complications [14].
Due to the patient’s non-compliance, the imple-
mentation of FIT in the reported case was impossible, 
therefore limiting the possibility of achieving tight 
glycaemic control.
Although tight metabolic control does not entirely 
prevent the development of chronic complications, 
a great number of patients have been reported to 
survive decades of diabetes without developing com-
plications at all. The Golden Years Study [15] described 
a group of patients suffering from T1DM for over 
50 years. Apart from diabetic retinopathy, which was 
present in 43% of patients, and cardiovascular disease, 
present in approximately 1/3 of them, the patients 
were free from long-term complications. The group 
was characterised by normal body weight, low insulin 
dose, and high HDL cholesterol. In the 50-year Medal-
ist Study [16], nearly one half of the patients did not 
report microvascular complications. In accordance with 
the aforementioned study, this group had significantly 
higher HDL cholesterol level and lower insulin dose, 
as well as lower triglycerides, comparing with those 
who developed complications. Physical activity was 
also associated with reduced risk of complications. Of 
note, there was no significant difference between the 
two groups regarding concentration of HbA1c, BMI, 
total cholesterol, or LDL cholesterol level. This lack of 
association between the development of complications 
and most metabolic parameters may suggest the role of 
other determinants, such as genetic factors, protecting 
certain patients from complications.
Conclusions
Tight metabolic control of diabetes, especially 
during early years of the disease, reduces the risk of 
long-term complications. However, despite better 
methods of treatment, there still are patients who de-
velop multiple complications. In most cases, the key fac-
tor influencing the outcome of the disease is patient’s 
awareness and their cooperation. Proper education, 
covering not only basic skills and knowledge, but also 
psychosocial aspects, as well as encouraging patient 
to actively participate in the treatment, are crucial in 
effective management of diabetes.
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